Institutional investors purchased a net $721.4 thousand shares of BSTC during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 52.51% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ABDIEL CAPITAL LP Bought 337.6 Thousand shares of Biospecifics Technologies...